Literature DB >> 30659799

Fibroblast growth factor 21: A role in cardiometabolic disorders and cardiovascular risk prediction?

Niki Katsiki1, Christos Mantzoros2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30659799     DOI： 10.1016/j.metabol.2019.01.005

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  3 in total

1.  The Effect of All Extremity High Intensity Interval Training on Athero-Protective Factors and Endothelial Function in Overweight and Obese Women.

Authors:  Volga Hovsepian; Sayad M Marandi; Fahimeh Esfarjani; Reihaneh Zavar; Masoumeh Sadeghi
Journal:  Int J Prev Med       Date:  2021-10-26

2.  Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21-AMPK pathway in mice fed a high fat diet.

Authors:  Yuanyuan Zhang; Ruili Yin; Jianan Lang; Ying Fu; Longyan Yang; Dong Zhao
Journal:  Diabetol Metab Syndr       Date:  2022-04-13       Impact factor: 3.320

Review 3.  The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms.

Authors:  Mengjie Xiao; Yufeng Tang; Shudong Wang; Jie Wang; Jie Wang; Yuanfang Guo; Jingjing Zhang; Junlian Gu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-19       Impact factor: 5.555
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.